Lonza Accelerates the Future of Pharma QC with Acquisition of Redberry and Its Breakthrough Red One™ Rapid Microbiology Platform

  Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One&trade...

October 29, 2025 | Wednesday | News
BD Showcases Next-Generation Drug Delivery and RFID Traceability Solutions at CPhI 2025

 BD (Becton, Dickinson and Company), a leading medical technology company, will feature the next generation of drug delivery and traceability s...

October 28, 2025 | Tuesday | News
Thermo Fisher Scientific Showcases Next-Generation Biopharma Solutions and AI-Driven Innovations at CPHI Frankfurt 2025

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...

October 28, 2025 | Tuesday | News
Vas Narasimhan Calls USD 12 Billion Avidity Acquisition a Defining Move to Advance Novartis Mission in Neuromuscular Disease Treatment

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases Advances the No...

October 27, 2025 | Monday | News
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop Next-Generation Mpox Vaccine

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-ba...

October 24, 2025 | Friday | News
Marc N. Casper Highlights Thermo Fisher’s 10% Adjusted EPS Growth and Strategic AI Collaboration with OpenAI in Strong Q3 2025 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 27, ...

October 23, 2025 | Thursday | Company results
ProImmune Expands UK Operations with New Global Headquarters at Oxford’s Oasis Park

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operationa...

October 23, 2025 | Thursday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News
Building Biopharma Resilience — Cytiva’s Pierre-Alain Ruffieux on Balancing Progress and Preparedness

Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...

October 20, 2025 | Monday | Interaction
Thermo Fisher Launches SwiftArrayStudio™ Microarray Analyzer to Transform Genetic Research and Precision Medicine

Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, ...

October 17, 2025 | Friday | News
SCYNEXIS to Receive $22 Million from GSK as Phase 3 MARIO Study on Invasive Candidiasis Is Terminated

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasis Scynexis...

October 16, 2025 | Thursday | Regulatory
Quotient Sciences and Biorasi Partner to Streamline Early Clinical Trials from IND to Proof-of-Concept

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO),...

October 15, 2025 | Wednesday | News
Excellergy Launches with $70M Series A to Redefine Allergy Treatment with First-in-Class Trifunctional ECRIs

-Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of alle...

October 14, 2025 | Tuesday | News
EarlyHealth Group Acquires 50% Stake in CYB3R to Boost Global Cybersecurity for Life Sciences

EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gu...

October 13, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close